The Zambia Medicines and Medical Supplies Agency (ZAMMSA) is pleased to announce that the country maintains a robust supply of Anti-Retroviral (ARV) drugs to meet patient demand. Currently, we have over six months’ supply of first, second, and third-line ARV drugs, ensuring that all patients undergoing Anti-Retroviral Treatment (ART) receive their necessary medications without interruption....

The Zambia Medicines and Medical Supplies Agency (ZAMMSA) commenced the distribution of the first ever long lasting injectable Antiretroviral Viral (ARV) drug, Cabotegravir Long-Acting (CAB-LA) commonly referred to as the Injectable PrEP for HIV prevention. On 9th of February 2024, Zambia become the first African country to receive 15,000 vials of the Injectable PrEP which...

Lusaka, 16th August 2024. The Zambia Medicines and Medical Supplies Agency (ZAMMSA) has in the last three months successfully attained a 77% distribution rate of health commodities to various health facilities across the country. In Cycle 2 of 2024, which ran from April to July, ZAMMSA successfully shipped 82 out of the 107 scheduled routes....

Lusaka, 29th August 2024. The Zambia Medicines and Medical Supplies Agency (ZAMMSA) has effectively commenced the payment of K450 million owed to suppliers for assorted essential medicines supplied to the Agency. The move aimed at boosting the local Pharmaceutical industry will see the immediate payment of around K450 million to suppliers who delivered health commodities...

Newly appointed Acting Director General, Mr. Luke Alutuli has stressed the need for commitment and hardwork in order for ZAMMSA to live up to it’s mandate of timely and efficient Procurement, Storage and Distribution of Medicines and Medical Supplies. Addressing members of staff when he was officially introduced by the Board, Mr. Alutuli emphasized the...